Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer
AUAUniversity31 Maalis 2017

Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

The goal of this knowledge-based activity is to improve clinicians' understanding of current immunotherapeutic agents for the treatment of bladder cancer and to increase their ability to improve patient outcomes and the management of adverse events. Educational grants provided by the following corportations: AstraZeneca, Bristol-Myers Squibb, Genentech, Merck

Jaksot(421)

Setting Up a Clinic In The Community Setting | The Role Of Chemotherapy Treatment

Setting Up a Clinic In The Community Setting | The Role Of Chemotherapy Treatment

This educational series is supported by independent educational grants from: AbbVie, Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Genomic Health, Merck, Sanofi Genz...

9 Heinä 201953min

AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment

AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

5 Heinä 20191h 46min

Genetic Testing in Advanced Prostate Cancer and Initial Management of Biochemical Recurrence

Genetic Testing in Advanced Prostate Cancer and Initial Management of Biochemical Recurrence

This educational series is supported by independent educational grants from: AbbVie, Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Genomic Health, Merck, Sanofi Genzy...

2 Heinä 201953min

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24584 Instructional Course Director(s) Eric Rovner, MD Medical...

27 Kesä 20191h 54min

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

AUA2019 077IC Establishing A Multidisciplinary Oncology Clinic With Advanced Therapeutics

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

20 Kesä 20191h 44min

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate Cancer

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

14 Kesä 20192h 1min

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

6 Kesä 20191h 49min

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24581 Instructional Course Director(s) Kathleen Kobashi, MD, F...

30 Touko 20191h 58min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-valo-minussa-2
aamukahvilla
jari-sarasvuo-podcast
rss-uskonto-on-tylsaa
rss-duodecim-lehti
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
rss-niinku-asia-on
kesken
salainen-paivakirja
psykologia
ihminen-tavattavissa-tommy-hellsten-instituutti
leveli
rss-tietoinen-yhteys-podcast-2